Gilead Sciences (France)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Gilead Sciences (France), France, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
56%
Total
Publications
187
Total Open
Publications
105
Total
Citations
4.5K
Open Access
Percentage
56%
Total
Publications
187
Total Open
Publications
105
Total
Citations
4.5K
Breakdown
Publisher Open
38%
Both
13%
Other Platform Open
5%
Closed
44%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 21%
20
Hybrid 28%
27
No Guarantees 51%
48
Other Platform Open
Domain 83%
29
Institution 26%
9
Other Internet 20%
7
Public 9%
3
Preprint 6%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 29 |
Europe PMC | Domain | 17 |
University of Zurich - Zurich Open Repository and Archive | Institution | 2 |
University of California - eScholarship University of California | Institution | 2 |
University of Bristol - Bristol Research | Institution | 2 |
Semantic Scholar | Public | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART | Other Internet | 2 |
DOI | Other Internet | 2 |
California Digital Library - eScholarship | Other Internet | 2 |
Zenodo | Public | 1 |